Wuhan Dazhong Dental Medical (2651) H2 2025 earnings summary

Executive summary

• FY2025 revenue fell 8.7% YoY to RMB371.6m; net profit fell 19.0% to RMB50.6m, while adjusted net profit declined 11.1% to RMB60.7m.

• Opened 8 dental out-patient departments and 2 clinics; recorded 729,404 customer visits, including 159,535 new visits, and operated 92 institutions at year-end.

• Proposed a final dividend of RMB0.668 per share, totaling RMB33.0m, subject to shareholder approval.

Financial highlights

• Revenue was RMB371.6m versus RMB407.1m in 2024; gross profit was RMB140.1m versus RMB152.3m.

• Profit before tax declined to RMB57.8m from RMB70.8m; net profit was RMB50.6m versus RMB62.5m.

• Adjusted net profit, a non-IFRS measure, was RMB60.7m versus RMB68.3m; it adjusts for preference-share fair-value changes, share-based payments and listing expenses.

Outlook and guidance

• Strategic priorities include strengthening core Central China operations, pursuing return-focused organic expansion and acquisitions, and investing in AI-enabled diagnosis, operations and customer service.

• Management plans to deepen regional penetration, improve operational efficiency and profitability, and use standardized systems to integrate new institutions.